On ECHEMI
Home > Drugs > Sodium Aescinate for Injection

Sodium Aescinate for Injection

Function and Efficacy

1. Pharmacology This product can promote the body to increase the plasma concentration of ACTH and cortisone, promote the secretion of PGF2alpha in the blood vessel wall, and remove free radicals in the body, thereby playing an anti-inflammatory and anti-exudative role, improving venous tension, accelerating venous blood flow, promoting lymphatic return, improving blood circulation and microcirculation, and protecting the blood vessel wall. 2. Toxicology No hemolysis was found at a daily dose of less than 0.5 mg per kilogram of body weight. Acute toxicity study: After intravenous injection of the LD50 dose, animals developed acute poisoning, mainly manifested as hemolytic hypoxic necrosis of solid organs (heart, liver, and kidney); it had a strong irritating effect on mucosa and muscle tissue. Chronic toxicity study: A dose equivalent to 1/5 of the LD50 was given intravenously to rabbits every day for 30 consecutive days, and no animal death occurred, and no pathological changes occurred in its solid organs. Teratogenicity test: No teratogenic effect. It was observed that the drug content in the amniotic fluid of pregnant women was high in the first 3 months, so it is recommended that pregnant women should not use it.

Ingredients

Sodium aescinate A and sodium aescinate B are triterpenoid saponins containing ester bonds extracted from the dried mature seeds of Aesculus fragrans, a plant of the Aesculaceae family.

Appearance

This product is white freeze-dried loose blocks.

Indication

It is used for cerebral edema, swelling caused by trauma or surgery, and also for venous reflux disorders.

Usage and Dosage

Intravenous injection or intravenous drip. For adults, take 0.1-0.4 mg/kg per day according to body weight, or take 5-10 mg of this product dissolved in 250 ml of 10% glucose injection or 0.9% sodium chloride injection for intravenous drip; or take 5-10 mg of this product dissolved in 10-20 ml of 10% glucose injection or 0.9% sodium chloride injection for intravenous push injection. Severe patients can be given multiple doses, but the total amount per day should not exceed 20 mg. The course of treatment is 7-10 days.

Adverse Reactions

1 Local pain and swelling may be seen at the injection site, which can be eliminated by hot compress. 2 Occasionally, allergic reactions may occur, which can be treated according to the principles of drug allergy treatment.

Precautions

1. Patients with renal damage, renal failure, or renal insufficiency are prohibited from using this product. 2. Pregnant women are prohibited from using this product. 3. Patients who are allergic to the ingredients of this product are prohibited from using this product.

Drug Interactions

Be cautious when using it in combination with the following drugs: 1. Drugs with high binding rate to serum proteins. 2. Drugs that can seriously damage renal function. 3. Corticosteroid drugs. 4. Drugs containing basic groups (precipitation may occur when used in combination).

Storage

Keep away from light and store in sealed container.

Packaging Specification

10mg

Manufacturer

Wuhan Pusheng Pharmaceutical Co., Ltd.

  • Founded in:

    1998-05-11
  • Address:

    No. 1, Miaoshan Sunshine Avenue, Jiangxia District, Wuhan
  • Tax NO.:

    91420000707090425F
  • Registered Funds:

    23.141141 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.